Company / Capital Expenditures
LEXICON PHARMACEUTICALS, INC. Capital Expenditures History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$470.0K
FY2025
5-year range
$87.0K / $1.3M
FY2021-FY2025
Trend
-64.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 10 years, ranging from $80,000 in FY2016 to $2M in FY2015.
Based on SEC 10-K filings.
$470,000 in FY2025 with a 10-year CAGR of -12.2%.
Declined from $1M to $470,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -12.2%
Key checks
Key Insights
- In FY2025, capital expenditures decreased 64.6% year-over-year.
- Peak capital expenditures was recorded in FY2015.
- Lowest capital expenditures in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $470.0K | -64.6% |
| FY2024 | $1.3M | +8.6% |
| FY2023 | $1.2M | +1303.4% |
| FY2019 | $87.0K | -62.3% |
| FY2018 | $231.0K | -74.6% |
| FY2017 | $910.0K | +1037.5% |
| FY2016 | $80.0K | -95.4% |
| FY2015 | $1.7M | +249.8% |
| FY2014 | $492.0K | -59.2% |
| FY2013 | $1.2M | +6.5% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026